Aridis Pharmaceuticals, Inc. Share Price
Equities
ARDS
US0403341045
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0625 USD | +4.17% | +5.93% | -10.84% |
Sales 2021 | 1.54M 120M | Sales 2022 | 3.09M 243M | Capitalization | 29.39M 2.31B |
---|---|---|---|---|---|
Net income 2021 | -42M -3.3B | Net income 2022 | -30M -2.35B | EV / Sales 2021 | 13.4 x |
Net cash position 2021 | 12.12M 951M | Net Debt 2022 | 1.25M 98.42M | EV / Sales 2022 | 9.91 x |
P/E ratio 2021 |
-0.62
x | P/E ratio 2022 |
-0.73
x | Employees | 37 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 85.16% |
1 day | +4.17% | ||
1 week | +5.93% | ||
1 month | +4.17% | ||
3 months | -19.04% | ||
6 months | -22.84% | ||
Current year | -10.84% |
Managers | Title | Age | Since |
---|---|---|---|
Vu Truong
CEO | Chief Executive Officer | 60 | 31/12/02 |
Eric Patzer
FOU | Founder | 75 | 31/12/02 |
Tamara Allen
DFI | Director of Finance/CFO | 57 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Hamilton
BRD | Director/Board Member | 79 | 31/03/15 |
Eric Patzer
FOU | Founder | 75 | 31/12/02 |
Vu Truong
CEO | Chief Executive Officer | 60 | 31/12/02 |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 0.0625 | +4.17% | 82,876 |
30/05/24 | 0.06 | +6.19% | 69,017 |
29/05/24 | 0.0565 | -4.40% | 93,450 |
28/05/24 | 0.0591 | +0.17% | 14,251 |
24/05/24 | 0.059 | +10.28% | 2,781 |
Delayed Quote OTC Markets, May 31, 2024 at 07:49 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-10.84% | 2.88M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- ARDS Stock